Shayne & Jacobs LLC Trims Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Shayne & Jacobs LLC reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.2% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 96,041 shares of the company’s stock after selling 240 shares during the quarter. HCA Healthcare accounts for about 9.8% of Shayne & Jacobs LLC’s holdings, making the stock its 2nd biggest position. Shayne & Jacobs LLC’s holdings in HCA Healthcare were worth $39,034,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in HCA. Vanguard Group Inc. lifted its stake in shares of HCA Healthcare by 0.4% in the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock worth $5,666,569,000 after acquiring an additional 60,304 shares during the period. Capital World Investors lifted its stake in shares of HCA Healthcare by 57.5% in the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after acquiring an additional 1,019,750 shares during the period. Darsana Capital Partners LP lifted its stake in shares of HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after acquiring an additional 400,000 shares during the period. TD Asset Management Inc lifted its stake in HCA Healthcare by 2.7% in the second quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock valued at $238,110,000 after buying an additional 19,812 shares during the period. Finally, Epoch Investment Partners Inc. lifted its stake in HCA Healthcare by 16.4% in the second quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock valued at $203,002,000 after buying an additional 88,948 shares during the period. 62.73% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

HCA has been the topic of several recent analyst reports. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft boosted their price target on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research note on Friday, June 28th. Leerink Partners upped their target price on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Truist Financial upped their target price on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Finally, StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Five equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and four have given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $377.17.

HCA Healthcare Stock Down 8.8 %

Shares of NYSE:HCA opened at $363.75 on Friday. The company has a market capitalization of $95.27 billion, a PE ratio of 18.13, a price-to-earnings-growth ratio of 1.44 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The business has a fifty day moving average price of $395.26 and a two-hundred day moving average price of $352.63. HCA Healthcare, Inc. has a 1 year low of $220.55 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $4.29 EPS. Analysts forecast that HCA Healthcare, Inc. will post 22.51 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.73%. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Insider Activity

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,345 shares of company stock valued at $5,747,945 in the last 90 days. Insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.